Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study
Osteoporos Int
.
2023 Nov;34(11):1975.
doi: 10.1007/s00198-023-06887-4.
Authors
Judith Everts-Graber
1
2
,
Harald Bonel
3
4
5
,
Daniel Lehmann
6
,
Brigitta Gahl
7
,
HansJörg Häuselmann
8
,
Ueli Studer
9
,
Hans-Rudolf Ziswiler
9
,
Stephan Reichenbach
10
11
,
Thomas Lehmann
9
Affiliations
1
OsteoRheuma Bern AG, Bahnhofplatz 1, CH- 3011, Bern, Switzerland.
[email protected]
.
2
Department of Rheumatology and Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
[email protected]
.
3
Campus Stiftung Lindenhof Bern, Swiss Institute for Translational and Entrepreneurial Medicine, Bern, Switzerland.
4
Department of Radiology, Lindenhof Hospital, Bern, Switzerland.
5
Department of Radiology, Inselspital, University of Bern, Bern, Switzerland.
6
Faculty of Medicine, University of Bern, Bern, Switzerland.
7
Clinical Trial Unit, University of Bern, Bern, Switzerland.
8
Zentrum Für Rheuma- Und Knochenerkrankungen, Klinik Im Park, Hirslanden Zurich, Switzerland.
9
OsteoRheuma Bern AG, Bahnhofplatz 1, CH- 3011, Bern, Switzerland.
10
Department of Rheumatology and Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
11
Institute for Social and Preventive Medicine, University of Bern, Bern, Switzerland.
PMID:
37592150
PMCID:
PMC10579170
DOI:
10.1007/s00198-023-06887-4
No abstract available
Publication types
Published Erratum